Trinity Biotech (TRIB) Cash from Investing Activities (2021 - 2024)
Trinity Biotech recorded quarterly Cash from Investing Activities of -$2.7 million in Q4 2024, down 207.07% quarter-over-quarter from -$891000.0 in Q4 2023, and down 207.07% year-over-year from $2.6 million in Q1 2024.
Trinity Biotech's Cash from Investing Activities history runs 4 years deep, the most recent figure standing at -$2.7 million for Q4 2024.
- In Q4 2024, Cash from Investing Activities fell 207.07% year-over-year to -$2.7 million; the TTM figure through Dec 2024 stood at -$5.7 million (down 33.31% YoY), while the FY2025 annual figure was -$6.2 million, up 72.91% from the prior year.
- Cash from Investing Activities came in at -$2.7 million for Q4 2024 at Trinity Biotech, down from -$891000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$1801.0 in Q2 2022 to a low of -$2.7 million in Q4 2024.
- A 4-year average of -$1.2 million and a median of -$1.0 million in 2022 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities surged 54.02% in 2022 and sank 207.07% in 2024, its largest moves.
- Trinity Biotech's Cash from Investing Activities stood at -$2.5 million in 2021, then surged by 54.02% to -$1.1 million in 2022, then gained by 21.7% to -$891000.0 in 2023, then tumbled by 207.07% to -$2.7 million in 2024.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$2.7 million, -$891000.0, and -$886000.0 for Q4 2024, Q4 2023, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.74 Mn |
| Dec 31, 2024 | -2.74 Mn |
| Dec 31, 2023 | -891,000.00 |
| Dec 31, 2023 | -891,000.00 |
| Sep 30, 2023 | -886,000.00 |
| Sep 30, 2023 | -886,000.00 |
| Dec 31, 2022 | -1.14 Mn |
| Dec 31, 2022 | -1.14 Mn |
| Sep 30, 2022 | -1.32 Mn |
| Sep 30, 2022 | -1.32 Mn |
| Jun 30, 2022 | -1,801.00 |
| Jun 30, 2022 | -1,801.00 |
| Dec 31, 2021 | -2.48 Mn |
| Dec 31, 2021 | -2.48 Mn |
| Jun 30, 2021 | -2,131.00 |
| Jun 30, 2021 | -2,131.00 |